- Prepare attendees for the Nephrology Board
Certification and Recertification Examinations
- Provide a timely, comprehensive, and thorough update for the
practicing nephrologists
- Translate the results of clinical investigations into practical use
in patient care
|
See individual talk files for faculty bios and disclosures.
|
|  |
|
Each talk is designated
for AMA PRA Category 1 credit&trade by the American Society of Nephrology.
Shorter talks are organized
into groups of two and
paired with a CME post-test,
which must be completed
along with an evaluation
form to earn CME Category
1 credits.
|
| | Date of Web Release: See
individual talks
CME Credit Eligible Through: February 28, 2010
CME Category 1 Credits/Completion Time: See individual
talks
Target Audiences: Nephrology
Board and Recertification candidates; practicing nephrologists
and internists.
Method of participation: Listen to the
talk, read the
PubMed abstracts linked to data slides and talk references, take
the post-test,
read the abstracts linked to post-test answer feedback material.
|
Chronic kidney disease affects 30-40 million Americans, of whom several
thousand require renal replacement therapy. These selected lectures
are chosen by the HDCN editor and ASN Postgraduate Medical Director
to reflect those areas of practice of greatest interest to the
clinician, and areas where recent progress has occurred. The
web extension of these ASN lectures will allow nephrologists
and other physicians who were unable to attend the live sessions
to gain similar benefit from these presentations.
| ACCREDITATION
AND DESIGNATION STATEMENTS: |
Accreditation Statement
The American Society of Nephrology is accredited by the Accreditation
Council for Continuing Medical Education to provide continuing
medical education for physicians.
CME Credit Designation Statement:
The American Society of Nephrology designates this educational activity for a maximum of (see each talk page for credit numbers) AMA PRA Category 1 Credits™.
Physicians should only claim credit commensurate with the extent of their participation in the activity.
| FACULTY DISCLOSURE
STATEMENT : |
In accordance with the disclosure policies of the Accreditation Council for Continuing Medical Education (ACCME) and FDA guidelines, it is a policy at the ASN for individuals who are in a position to control the content of an educational activity to disclose to the activity participants: 1) the existence of all relevant financial relationships with any commercial interests or other relationships with the manufacturers of any commercial products/devices, or providers of commercial services, that relate to the content of their presentation/materials, or the commercial contributors of this activity, that could be perceived as a real or apparent conflict of interest; for this purpose we consider relationships of the person involved in the CME activity to include financial relationships of a spouse or partner and 2) the identification of a commercial product/device that is unlabeled for use or an investigational use of a product/device not yet approved.
Based on the disclosures provided, the ASN is responsible for identifying and resolving all conflicts of interest prior to presenting the educational activity to the learner. The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from involvement in CME, but rather to ensure that ASN CME activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. In addition, all faculty members were instructed to provide balanced, scientifically rigorous, and evidence-based presentations.
Speaker disclosures are posted on each individual talk page.
| DISCLOSURE OF
UNLABELED USE: |
This educational activity may contain discussion of
published and/or
investigational uses of agents that are not indicated by FDA. The
American Society of Nephrology and HDCN do not recommend the
use of any agent outside of the labeled indications. Please refer
to the official prescribing information for each product for discussion of approved
indications, contraindications and warnings. Speaker disclosure about individual talks is posted on each individual talk page.
Participants have an implied responsibility to use the newly acquired
information to enhance patient outcomes and their own professional
development. The information presented in this activity is not
meant to serve as a guideline for patient management. Any procedures,
medications, or other courses of diagnosis or treatment discussed
or suggested in this activity should not be used by clinicians
without evaluation of their patient's conditions and possible
contraindications on dangers in use, review of any applicable
manufacturer's product information, and comparison with recommendations
of other authorities.
To complete this educational activity, the user will need Windows (XP or later) or Macintosh (version 9.0 or later) operating software, a connection to the internet with a 28.8 kbps MODEM or better. The computer should have an audio card with speakers. An audio player, either the Windows Media Player (version 7.0 or later) from Microsoft or the Flash Player plug-in from Adobe (Version 7 or later, from http://www.adobe.com) is required, and either can be downloaded for free per instructions on the individual lecture pages. Acrobat Reader is required to print the CME certificate, and this can be download free from www.adobe.com.
For any questions concerning this specific activity please send
an email to 
or email@asn-online.org,
or call HDCN at 630-325-3276 during normal business hours, central standard time.
For any general questions concerning ASN CME, please contact the American Society of Nephrology.
| |
